Abstract
Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand.
Highlights
Platelets are circulating cytoplasmic fragments of megakaryocytes, which reside in the bone marrow
The platelets for the experiments were isolated from 9 individual donors, and we noted some individual variation in the range of basal oxygen consumption rate (OCR) from 8–15 pmol/min/μg protein and the extracellular acidification rate (ECAR) measurements ranged from 3–6 mpH/min/μg protein
It is clear that both glycolysis and oxidative phosphorylation are active metabolic pathways in platelets, the metabolic plasticity in the use of oxidative substrates for platelet aggregation remains unexplored [6,11,12,13,14,15]
Summary
Platelets are circulating cytoplasmic fragments of megakaryocytes, which reside in the bone marrow. Platelets do not have nuclei, but contain a number of organelles such as mitochondria, lysosomes and peroxisomes [1]. The primary role of platelets is to mediate hemostasis through thrombus formation. Thrombin is a pro-coagulant factor that is produced during the PLOS ONE | DOI:10.1371/journal.pone.0123597. This does not alter the auhtors' adherence to PLOS ONE policies on sharing data and materials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.